FDA approves Binosto for osteoporosis

FDA approved an NDA for Binosto alendronate from EffRx Pharmaceuticals S.A. (Freienbach, Switzerland) to treat osteoporosis. EffRx will launch the alendronate effervescent tablets in the U.S. in 3Q12....